Literature DB >> 4762587

Treatment of uremic bone disease. Action of 5,6-trans-25-hydroxycholecalciferol (a vitamin D-analog) in chronic renal failure.

D von Herrath, K Schaefer, D Kraft, H G Grigoleit, P Koeppe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4762587     DOI： 10.1007/bf01468254

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


× No keyword cloud information.
  17 in total

Review 1.  [Vitamin D metabolism and chronic kidney insufficiency].

Authors:  K Schaefer; D von Herrath; D Kraft
Journal:  Dtsch Med Wochenschr       Date:  1973-07-06       Impact factor: 0.628

2.  [Studies on intestinal 47 Calcium absorption in healthy subjects and patients with chronic renal failure as well as on the significance of vitamin D 3 or 25-hydroxycholecalciferol therapy in renal osteopathy].

Authors:  R D Hesch; W Gerlach; H V Henning; D Emrich; F Scheler; R Kattermann
Journal:  Dtsch Med Wochenschr       Date:  1972-11-10       Impact factor: 0.628

3.  Action of 1,25-dihydroxycholecalciferol, a potent, kidney-produced metabolite of vitamin D, in uremic man.

Authors:  A S Brickman; J W Coburn; A W Norman
Journal:  N Engl J Med       Date:  1972-11-02       Impact factor: 91.245

4.  5,6-Trans isomers of cholecalciferol and 25-hydroxycholecalciferol. Substitutes for 1,25-dihydroxycholecalciferol in anephric animals.

Authors:  M F Holick; M Garabedian; H F DeLuca
Journal:  Biochemistry       Date:  1972-07-04       Impact factor: 3.162

5.  Biological activity of 1,25-dihydroxycholecalciferol.

Authors:  J Omdahl; M Holick; T Suda; Y Tanaka; H F DeLuca
Journal:  Biochemistry       Date:  1971-07-20       Impact factor: 3.162

6.  1,25-dihydroxycholecalciferol: the metabolite of vitamin D responsible for increased intestinal calcium transport.

Authors:  C A Frolik; H F Deluca
Journal:  Arch Biochem Biophys       Date:  1971-11       Impact factor: 4.013

7.  Studies on calciferol metabolism. I. Production of vitamin D metabolite 4B from 25-OH-cholecalciferol by kidney homogenates.

Authors:  A W Norman; R J Midgett; J F Myrtle; H G Nowicki
Journal:  Biochem Biophys Res Commun       Date:  1971-03-19       Impact factor: 3.575

8.  Unique biosynthesis by kidney of a biological active vitamin D metabolite.

Authors:  D R Fraser; E Kodicek
Journal:  Nature       Date:  1970-11-21       Impact factor: 49.962

9.  Arrest of hyperparathyroid bone disease with dihydrotachysterol in patients undergoing chronic hemodialysis.

Authors:  M Kaye; G Chatterjee; G F Cohen
Journal:  Ann Intern Med       Date:  1970-08       Impact factor: 25.391

10.  [Studies on the therapy of uremic osteopathy].

Authors:  K Schaefer; P Schaefer; P Koeppe; A Opitz; D Höffler
Journal:  Dtsch Med Wochenschr       Date:  1969-01       Impact factor: 0.628
View more
  2 in total

1.  Pharmacokinetics of 5,6-trans-25-hydroxycholecalciferol, a synthetic analogue of vitamin D3, in man.

Authors:  G Offermann; K Schaefer; H G Grigoleit; F Dittmar
Journal:  Eur J Clin Pharmacol       Date:  1975-04-04       Impact factor: 2.953

2.  The effect of 5,6-trans-25-hydroxycholecalciferol in relative vitamin D resistancy.

Authors:  D Kraft; G Offermann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-03       Impact factor: 3.000
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.